Patrick Soon Shiong Immunity Bio, Inc. (IBRX) insider trading activity

Patrick Soon Shiong is Director of ImmunityBio, Inc.. Currently has a direct ownership of 29.5 Million shares of IBRX, which is worth approximately $89.5 Million. The most recent transaction as insider was on Feb 22, 2025, when has been sold 42,071 shares (Common Stock) at a price of $3.42 per share, resulting in proceeds of $143,882. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.5M

0.25% 3M change

0.25% 12M change

Total Value Held $89.5 Million

PATRICK SOON-SHIONG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2025	SELL Payment of exercise price or tax liability	$143,882 $3.42 p/Share	42,071 Reduced 0.14%	29,546,190 Common Stock
Feb 22 2025	BUY Exercise of conversion of derivative security	-	114,329 Added 0.38%	29,588,261 Common Stock
Mar 09 2021	BUY Other acquisition or disposition	-	5,723,182 Added 16.26%	29,473,932 Common Stock

Also insider at

NantHealth, Inc. Healthcare

Chief Executive Officer